355 related articles for article (PubMed ID: 32915358)
1. HILIC-UPLC-MS for high throughput and isomeric N-glycan separation and characterization in Congenital Disorders Glycosylation and human diseases.
Messina A; Palmigiano A; Esposito F; Fiumara A; Bordugo A; Barone R; Sturiale L; Jaeken J; Garozzo D
Glycoconj J; 2021 Apr; 38(2):201-211. PubMed ID: 32915358
[TBL] [Abstract][Full Text] [Related]
2. Relative quantification of plasma N-glycans in type II congenital disorder of glycosylation patients by mass spectrometry.
Barbosa EA; Fontes NDC; Santos SCL; Lefeber DJ; Bloch C; Brum JM; Brand GD
Clin Chim Acta; 2019 May; 492():102-113. PubMed ID: 30776362
[TBL] [Abstract][Full Text] [Related]
3. CSF N-Glycomics Using High-Throughput UPLC-ESI Techniques in Alzheimer's Disease.
Messina A; Barone R; Sturiale L; Zappia M; Palmigiano A; Garozzo D
Methods Mol Biol; 2024; 2785():37-48. PubMed ID: 38427186
[TBL] [Abstract][Full Text] [Related]
4. ALG12-CDG: novel glycophenotype insights endorse the molecular defect.
Sturiale L; Bianca S; Garozzo D; Terracciano A; Agolini E; Messina A; Palmigiano A; Esposito F; Barone C; Novelli A; Fiumara A; Jaeken J; Barone R
Glycoconj J; 2019 Dec; 36(6):461-472. PubMed ID: 31529350
[TBL] [Abstract][Full Text] [Related]
5. Increased Clinical Sensitivity and Specificity of Plasma Protein
Chen J; Li X; Edmondson A; Meyers GD; Izumi K; Ackermann AM; Morava E; Ficicioglu C; Bennett MJ; He M
Clin Chem; 2019 May; 65(5):653-663. PubMed ID: 30770376
[TBL] [Abstract][Full Text] [Related]
6. Serum N-glycan and O-glycan analysis by mass spectrometry for diagnosis of congenital disorders of glycosylation.
Xia B; Zhang W; Li X; Jiang R; Harper T; Liu R; Cummings RD; He M
Anal Biochem; 2013 Nov; 442(2):178-85. PubMed ID: 23928051
[TBL] [Abstract][Full Text] [Related]
7. Rapid Preparation of Released N-Glycans for HILIC Analysis Using a Labeling Reagent that Facilitates Sensitive Fluorescence and ESI-MS Detection.
Lauber MA; Yu YQ; Brousmiche DW; Hua Z; Koza SM; Magnelli P; Guthrie E; Taron CH; Fountain KJ
Anal Chem; 2015; 87(10):5401-9. PubMed ID: 25927596
[TBL] [Abstract][Full Text] [Related]
8. MALDI-MS profiling of serum O-glycosylation and N-glycosylation in COG5-CDG.
Palmigiano A; Bua RO; Barone R; Rymen D; Régal L; Deconinck N; Dionisi-Vici C; Fung CW; Garozzo D; Jaeken J; Sturiale L
J Mass Spectrom; 2017 Jun; 52(6):372-377. PubMed ID: 28444691
[TBL] [Abstract][Full Text] [Related]
9. Comparing MALDI-MS, RP-LC-MALDI-MS and RP-LC-ESI-MS glycomic profiles of permethylated N-glycans derived from model glycoproteins and human blood serum.
Hu Y; Mechref Y
Electrophoresis; 2012 Jul; 33(12):1768-77. PubMed ID: 22740465
[TBL] [Abstract][Full Text] [Related]
10. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous Release and Labeling of O- and N-Glycans Allowing for Rapid Glycomic Analysis by Online LC-UV-ESI-MS/MS.
Wang C; Lu Y; Han J; Jin W; Li L; Zhang Y; Song X; Huang L; Wang Z
J Proteome Res; 2018 Jul; 17(7):2345-2357. PubMed ID: 29775069
[TBL] [Abstract][Full Text] [Related]
12. Mass spectrometry glycophenotype characterization of ALG2-CDG in Argentinean patients with a new genetic variant in homozygosis.
Papazoglu GM; Cubilla M; Pereyra M; de Kremer RD; Pérez B; Sturiale L; Asteggiano CG
Glycoconj J; 2021 Apr; 38(2):191-200. PubMed ID: 33644825
[TBL] [Abstract][Full Text] [Related]
13. Development and application of a robust N-glycan profiling method for heightened characterization of monoclonal antibodies and related glycoproteins.
Shang TQ; Saati A; Toler KN; Mo J; Li H; Matlosz T; Lin X; Schenk J; Ng CK; Duffy T; Porter TJ; Rouse JC
J Pharm Sci; 2014 Jul; 103(7):1967-1978. PubMed ID: 24840237
[TBL] [Abstract][Full Text] [Related]
14. Polysialylated N-glycans identified in human serum through combined developments in sample preparation, separations, and electrospray ionization-mass spectrometry.
Kronewitter SR; Marginean I; Cox JT; Zhao R; Hagler CD; Shukla AK; Carlson TS; Adkins JN; Camp DG; Moore RJ; Rodland KD; Smith RD
Anal Chem; 2014 Sep; 86(17):8700-10. PubMed ID: 25118826
[TBL] [Abstract][Full Text] [Related]
15. Separation and Identification of Permethylated Glycan Isomers by Reversed Phase NanoLC-NSI-MS
Kurz S; Sheikh MO; Lu S; Wells L; Tiemeyer M
Mol Cell Proteomics; 2021; 20():100045. PubMed ID: 33376194
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 2-Aminobenzamide, Procainamide and
Keser T; Pavić T; Lauc G; Gornik O
Front Chem; 2018; 6():324. PubMed ID: 30094234
[TBL] [Abstract][Full Text] [Related]
17. Simplifying Glycan Profiling through a High-Throughput Micropermethylation Strategy.
Shajahan A; Supekar NT; Chapla D; Heiss C; Moremen KW; Azadi P
SLAS Technol; 2020 Aug; 25(4):367-379. PubMed ID: 32364434
[TBL] [Abstract][Full Text] [Related]
18. Comparison of ZIC-HILIC and graphitized carbon-based analytical approaches combined with exoglycosidase digestions for analysis of glycans from monoclonal antibodies.
Mauko L; Lacher NA; Pelzing M; Nordborg A; Haddad PR; Hilder EF
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Dec; 911():93-104. PubMed ID: 23217312
[TBL] [Abstract][Full Text] [Related]
19. Reductive chemical release of N-glycans as 1-amino-alditols and subsequent 9-fluorenylmethyloxycarbonyl labeling for MS and LC/MS analysis.
Wang C; Qiang S; Jin W; Song X; Zhang Y; Huang L; Wang Z
J Proteomics; 2018 Sep; 187():47-58. PubMed ID: 29885470
[TBL] [Abstract][Full Text] [Related]
20. Glycine additive enhances sensitivity for N- and O-glycan analysis with hydrophilic interaction chromatography-electrospray ionization-mass spectrometry.
Guo L; Nayak S; Mao Y; Li N
Anal Biochem; 2021 Dec; 635():114447. PubMed ID: 34742721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
